Molecular imaging of active coronary micro-calcification with 18 F-NaF and PET: emergence of a new biomarker of the vulnerable atherosclerotic plaque?

Ahmadi A Argulian E Leipsic J , et al. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74: 1608–1617.

Dudas K Lappas G Stewart S , et al. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 2011; 123: 46–52.

Tarkin JM Joshi FR Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 2014; 11: 443–457.

Rudd JH Narula J Strauss HW , et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 2010; 55: 2527–2535.

Nie X Elvington A Laforest R , et al. (64)Cu-ATSM positron emission tomography/magnetic resonance imaging of hypoxia in human atherosclerosis. Circ Cardiovasc Imaging 2020; 13: e009791.

De Backer GG. On the use of models to estimate the total risk of developing atherosclerotic cardiovascular disease. Eur J Prev Cardiol, Epub ahead of print 13 February 2020. DOI: 10.1177/2047487320902747.

Temporelli PL. Risk scores, atherosclerotic cardiovascular disease and the crystal ball. Eur J Prev Cardiol, Epub ahead of print 13 February 2020. DOI: 10.1177/2047487320903157.

Dweck MR Chow MW Joshi NV , et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 2012; 59: 1539–48.

Joshi NV Vesey AT Williams MC , et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014; 383: 705–713.

Florea A Morgenroth A Brucerius J , et al. Locking and loading the bullet against micro-calcification. Eur J Prev Cardiol, Epub ahead of print 2 March 2020. DOI: 10.1177/2047487320911138.